ORGANIC
LETTERS
2012
Vol. 14, No. 9
2234–2237
Semipinacol Rearrangement of Cis-Fused
β-Lactam Diols into Keto-Bridged Bicyclic
Lactams
Richard S. Grainger,*,† Marie Betou,† Louise Male,† Mateusz B. Pitak,‡ and
Simon J. Coles‡
School of Chemistry, University of Birmingham, Edgbaston, Birmingham B15 2TT, U.K.,
and National Crystallography Service, School of Chemistry, University of Southampton,
Southampton SO17 1BJ, U.K.
Received March 9, 2012
ABSTRACT
The 6-azabicyclo[3.2.1]octane ring system, prevalent in a range of biologically active molecules, is prepared through a novel semipinacol
rearrangement utilizing a cyclic phosphorane or sulfite intermediate. The rearrangement proceeds with exclusive N-acyl group migration of a
β-lactam ring and results in carbonyl functionality at the 7- and bridging 8-position of the bicycle. Precursor ring-fused β-lactam diols are prepared
through a sequence of 4-exo trig carbamoyl radical cyclization, regioselective dithiocarbamate group elimination, and dihydroxylation.
The 6-azabicyclo[3.2.1]octane ring system is found in a
wide variety of biologically active, natural1À8 and non-
natural products.9À11 We have targeted the 7,8-dioxo-6-
azabicyclo[3.2.1]octane core structure 1 as a potential
useful building block, particularly for the synthesis of
C-8 substituted variants.3À8 In this letter we report the
synthesis of 1 based on a novel semipinacol rearrangement
of a cis-fused β-lactam (Scheme 1).12,13
(6) Sarain A: Becker, M. H.; Chua, P.; Downham, R.; Douglas, C. J.;
Garg, N. K.; Hiebert, S.; Jaroch, S.; Matsuoka, R. T.; Middleton, J. A.;
Ng, F. W.; Overman, L. E. J. Am. Chem. Soc. 2007, 129, 11987–12002.
(7) Peduncularine: (a) Hodgson, D. M.; Shelton, R. E.; Moss, T. A.;
Dekhane, M. Org. Lett. 2010, 12, 2834–2837. (b) The first total synthesis
of peduncularine exploits a keto-bridged bicyclic lactam as a key
intermediate: Klaver, W. J.; Hiemstra, H.; Speckamp, W. N. J. Am.
Chem. Soc. 1989, 111, 2588–2595.
† University of Birmingham.
‡ University of Southampton.
(8) Nominine: Peese, K. M.; Gin, D. Y. Chem.;Eur. J. 2008, 14,
1654–1665.
(1) Securinega alkaloids: Weinreb, S. Nat. Prod. Rep. 2009, 26, 758–
775.
(2) Aphanorphine: Grainger, R. S.; Welsh, E. J. Angew. Chem., Int.
Ed. 2007, 46, 5377–5380.
(3) Lyconadin A: (a) Beshore, D. C.; Smith, A. B. J. Am. Chem. Soc.
2008, 130, 13778–13789. (b) West, S. P.; Bisai, A.; Lim, A. D.; Narayan,
R. R.; Sarpong, R. J. Am. Chem. Soc. 2009, 131, 11187–11194. (c)
Nishimura, T.; Unni, A. K.; Yokoshima, S.; Fukuyama, T. J. Am.
Chem. Soc. 2011, 133, 418–419.
(9) Takeda, M.; Inoue, H.; Noguchi, H. K.; Honma, Y.; Kawamori,
M.; Tsukamoto, G.; Yamawaki, Y.; Saito, S.; Aoe, K.; Date, T.;
Nurimoto, S.; Hayashi, G. J. Med. Chem. 1977, 20, 221–228.
(10) (a) Triggle, D. J.; Kwon, Y. W.; Abraham, P.; Pitner, J. B.;
Mascarella, S. W.; Carroll, F. I. J. Med. Chem. 1991, 34, 3164–3171. (b)
Carroll, F. I.; Abraham, P.; Mascarella, S. W.; Singh, P.; Moreland,
C. G.; Sanker, S. S.; Kwon, Y. W.; Triggle, D. J. J. Med. Chem. 1991, 34,
1436–1440.
(11) Quirante, J.; Vila, X.; Bonjoch, J.; Kozikowski, A. P.; Johnson,
K. M. Bioorg. Med. Chem. 2004, 12, 1383–1391.
(4) Actinobolamine: Holmes, A. B.; Kee, A.; Ladduwahetty, T.;
Smith, D. F. J. Chem. Soc., Chem. Commun. 1990, 1412–1414.
(5) (a) Caldaphnidine M: Zhang, C.-R.; Yang, S.-P.; Yue, J.-M. J.
Nat. Prod. 2008, 71, 1663–1668. (b) Calyciphylline F: Saito, S.; Kubota,
T.; Kobayashi, J. Tetrahedron Lett. 2007, 48, 3809–3812. (c) Calyciphyl-
line D: Saito, S.; Kubota, T.; Fukushi, E.; Kawabata, J.; Zhang, H.;
Kobayashi, J. Org. Lett. 2007, 9, 1207–1209.
(12) For a review of the semipinacol rearrangement, see: Song, Z.-L.;
Fan, C.-A.; Tu, Y.-Q. Chem. Rev. 2011, 111, 7523–7556.
(13) A related rearrangement in the all carbocyclic [4.2.0]-ring system
is hampered by the instability of the bridged 1,3-dicarbonyl product:
Blanchard, A. N.; Burnell, D. J. Tetrahedron Lett. 2001, 42, 4779–4781.
r
10.1021/ol300605y
Published on Web 04/18/2012
2012 American Chemical Society